Related Experiment Video
Updated: Sep 8, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Morphometric similarity deviations in stimulant use disorder point towards abnormal brain ageing
Peter Zhukovsky1, George Savulich2, Sarah Morgan2
1Department of Psychology, University of Cambridge, Cambridge, UK.
Chronic stimulant drug use accelerates brain aging, altering brain structure and function. Morphometric similarity mapping reveals abnormal aging patterns, offering potential biomarkers for this condition.
Area of Science:
- Neuroscience
- Addiction Research
- Brain Imaging
Background:
- Chronic drug use adversely affects aging, impacting health and quality of life.
- Biomarkers for accelerated brain aging in stimulant use disorder are poorly understood.
Purpose of the Study:
- To investigate biomarkers of abnormal brain aging in stimulant use disorder using morphometric similarity network mapping.
- To compare brain morphometric similarity and neuropsychological function between stimulant users and healthy controls.
Main Methods:
- Utilized morphometric similarity network mapping, a novel structural connectomics approach.
- Mapped cross-sectional morphometric similarity trajectories in a normative aging sample (n=665).
- Compared morphometric similarity and neuropsychological function in patients with stimulant use disorder (n=183) and healthy controls (n=148).
Main Results:
- Identified significantly altered mean regional morphometric similarity in 43 cortical regions, including frontal, temporal, parietal, and occipital areas.
- Observed deviations from normative aging trajectories in stimulant use disorder patients, suggesting abnormal brain aging.
- Found deficits in paired associates learning, consistent with neuropathology linked to both aging and stimulant use disorder.
Conclusions:
- Morphometric similarity mapping shows promise as a biomarker for brain aging in health and disease.
- This method may complement existing neuropsychological markers for age-related cognitive decline.
- Further research into neuropathological aging mechanisms in stimulant use disorder is crucial for developing age-appropriate treatments.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

